Haru Kato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Haru Kato has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Hideaki Kato
Toyokawa City Hospital, Aichi, Japan
4 shared publicationsMitsutoshi Senoh
Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan
4 shared publicationsTadashi Fukuda
Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan
3 shared publicationsAkiko Higuchi
National Hospital Organization Tokyo Medical Center, Tokyo, Japan
2 shared publicationsCedric Mahe
Sanofi Pasteur, Lyon, France
2 shared publicationsDaisuke Suzuki
Kameda Medical Center, Chiba, Japan
2 shared publications
Latest Publications
- Open Access
- 24 December 2020
- Published by MDPI AG in Microorganisms
- Vol. 9  (1) , 34
Surface Layer Protein A Expressed in Clostridioides difficile DJNS06-36 Possesses an Encephalitogenic Mimotope of Myelin Basic Protein
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Recent studies suggest that migration of Th1 and Th17 cells specific for enteric bacteria from the gut to the CNS may lead to the initiation and/or exacerbation of autoimmune diseases including MS. Human leukocyte antigen (HLA)-DR15 is an MHC class II (MHCII) haplotype highly associated with the development of MS that contains the two HLA-DRB* genes, DRB1*1501 (DR2b) and DRB5*0101 (DR2a). To identify enteric bacteria which harbor antigenic epitopes that activate myelin-specific T cells and drive CNS inflammation, we screened for enteric bacteria which express cross-reactive epitopes (‘mimotopes’) of an immunodominant myelin basic protein 89–98 (MBP89-98) epitope. Based on known MHCII HLA-DR2a amino acid binding motifs and cultivation with splenic T cells isolated from MBP-T cell receptor (TCR)/DR2a transgenic (Tg) mice, we discovered that a certain variant of surface layer protein A (SLPA), which is expressed by a subtype of Clostridioides difficile, contains an amino acid sequence that activates MBP89-98-reactive T cells. Furthermore, activation of MBP-specific T cells by SLPA upon active immunization induced experimental autoimmune encephalomyelitis (EAE) in MBP-TCR/DR2a Tg mice. This study suggests that a unique strain of C. difficile possesses an encephalitogenic mimotope of MBP that activates autoreactive, myelin-specific T cells.
- 24 December 2020
- Published by MDPI AG in Microorganisms
- Vol. 9  (1) , 34
Open AccessSurface Layer Protein A Expressed in Clostridioides difficile DJNS06-36 Possesses an Encephalitogenic Mimotope of Myelin Basic Protein
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Recent studies suggest that migration of Th1 and Th17 cells specific for enteric bacteria from the gut to the CNS may lead to the initiation and/or exacerbation of autoimmune diseases including MS. Human leukocyte antigen (HLA)-DR15 is an MHC class II (MHCII) haplotype highly associated with the development of MS that contains the two HLA-DRB* genes, DRB1*1501 (DR2b) and DRB5*0101 (DR2a). To identify enteric bacteria which harbor antigenic epitopes that activate myelin-specific T cells and drive CNS inflammation, we screened for enteric bacteria which express cross-reactive epitopes (‘mimotopes’) of an immunodominant myelin basic protein 89–98 (MBP89-98) epitope. Based on known MHCII HLA-DR2a amino acid binding motifs and cultivation with splenic T cells isolated from MBP-T cell receptor (TCR)/DR2a transgenic (Tg) mice, we discovered that a certain variant of surface layer protein A (SLPA), which is expressed by a subtype of Clostridioides difficile, contains an amino acid sequence that activates MBP89-98-reactive T cells. Furthermore, activation of MBP-specific T cells by SLPA upon active immunization induced experimental autoimmune encephalomyelitis (EAE) in MBP-TCR/DR2a Tg mice. This study suggests that a unique strain of C. difficile possesses an encephalitogenic mimotope of MBP that activates autoreactive, myelin-specific T cells.
- 1 March 2020
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 26  (3) , 305-308
Fatal fulminant Clostridioides difficile colitis caused by Helicobacter pylori eradication therapy; a case report
- 1 March 2020
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 26  (3) , 305-308
Fatal fulminant Clostridioides difficile colitis caused by Helicobacter pylori eradication therapy; a case report
- 1 December 2018
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 24  (12) , 980-982
Tetanus in a partially immunized child
- 1 December 2018
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 24  (12) , 980-982
Tetanus in a partially immunized child
- 1 October 2018
- Published by Elsevier in Microbial Pathogenesis
- Vol. 123, 42-46
Development of vaccine for Clostridium difficile infection using membrane fraction of nontoxigenic Clostridium difficile
- 1 October 2018
- Published by Elsevier in Microbial Pathogenesis
- Vol. 123, 42-46
Development of vaccine for Clostridium difficile infection using membrane fraction of nontoxigenic Clostridium difficile
- Open Access
- 18 September 2017
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 16  (1) , 1-4
A childhood-onset intestinal toxemia botulism during chemotherapy for relapsed acute leukemia
Botulism is a potentially fatal infection characterized by progressive muscle weakness, bulbar paralysis, constipation and other autonomic dysfunctions. A recent report suggested that cancer chemotherapy might increase the risk for the intestinal toxemia botulism in both adults and children. We report a 5-year-old boy, who developed general muscle weakness, constipation, ptosis and mydriasis during the third induction therapy for relapsed acute myeloid leukemia. He had recent histories of multiple antibiotic therapy for bacteremia and intake of well water at home. Repeated bacterial cultures identified Clostridium botulinum producing botulinum neurotoxin A. Botulinum toxin A was isolated from his stools at 17, 21, and 23 days after the onset. Symptoms were self-limiting, and were fully recovered without anti-botulinum toxin globulin therapy. This is the second report of a pediatric case with cancer chemotherapy-associated intestinal toxemia botulism. Our case provides further evidence that the immunocompromised status due to anti-cancer treatments increases the risk for the development of botulism at all ages in childhood.
- 18 September 2017
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 16  (1) , 1-4
Open AccessA childhood-onset intestinal toxemia botulism during chemotherapy for relapsed acute leukemia
Botulism is a potentially fatal infection characterized by progressive muscle weakness, bulbar paralysis, constipation and other autonomic dysfunctions. A recent report suggested that cancer chemotherapy might increase the risk for the intestinal toxemia botulism in both adults and children. We report a 5-year-old boy, who developed general muscle weakness, constipation, ptosis and mydriasis during the third induction therapy for relapsed acute myeloid leukemia. He had recent histories of multiple antibiotic therapy for bacteremia and intake of well water at home. Repeated bacterial cultures identified Clostridium botulinum producing botulinum neurotoxin A. Botulinum toxin A was isolated from his stools at 17, 21, and 23 days after the onset. Symptoms were self-limiting, and were fully recovered without anti-botulinum toxin globulin therapy. This is the second report of a pediatric case with cancer chemotherapy-associated intestinal toxemia botulism. Our case provides further evidence that the immunocompromised status due to anti-cancer treatments increases the risk for the development of botulism at all ages in childhood.
- 1 May 2010
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 59  (5) , 556-562
Typing of Clostridium difficile isolates endemic in Japan by sequencing of slpA and its application to direct typing
A typing system forClostridium difficileusing sequencing of the surface-layer protein A encoding gene (slpA) was evaluated and used to analyse clinical isolates in Japan. A total of 160 stool specimens from symptomatic patients in Japan was examined and 87C. difficileisolates were recovered.slpAsequence typing was found to have reliable typability and discriminatory power in comparison with PCR ribotyping, and the typing results were highly reproducible and comparable.slpAsequence typing was used to typeC. difficilein DNA extracted directly from stool specimens. Among the 90 stool specimens in which direct typing results were obtained, 77 specimens were positive forC. difficileculture, and typing results from isolated strains agreed with those from direct typing in all 77 specimens. TheslpAsequence type smz was dominant at all four hospitals examined, and this endemic type was detected by culture and/or direct typing in 61 (62 %) of 99 stool specimens positive for toxic culture and/or directslpAsequence typing. Comparison of epidemic strains reported throughout the world revealed one isolate identified asslpAsequence type gc8, which was found to correspond to PCR ribotype 027 (BI/NAP1/027), whereas no isolates were found with theslpAgene identical to that of PCR ribotype 078 strain.slpAsequence typing is valuable for comparison ofC. difficilestrains epidemic in diverse areas because the typing results are reproducible and can easily be shared. In addition,slpAsequence typing could be applied to direct typing without culture.
- 1 May 2010
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 59  (5) , 556-562
Typing of Clostridium difficile isolates endemic in Japan by sequencing of slpA and its application to direct typing
A typing system forClostridium difficileusing sequencing of the surface-layer protein A encoding gene (slpA) was evaluated and used to analyse clinical isolates in Japan. A total of 160 stool specimens from symptomatic patients in Japan was examined and 87C. difficileisolates were recovered.slpAsequence typing was found to have reliable typability and discriminatory power in comparison with PCR ribotyping, and the typing results were highly reproducible and comparable.slpAsequence typing was used to typeC. difficilein DNA extracted directly from stool specimens. Among the 90 stool specimens in which direct typing results were obtained, 77 specimens were positive forC. difficileculture, and typing results from isolated strains agreed with those from direct typing in all 77 specimens. TheslpAsequence type smz was dominant at all four hospitals examined, and this endemic type was detected by culture and/or direct typing in 61 (62 %) of 99 stool specimens positive for toxic culture and/or directslpAsequence typing. Comparison of epidemic strains reported throughout the world revealed one isolate identified asslpAsequence type gc8, which was found to correspond to PCR ribotype 027 (BI/NAP1/027), whereas no isolates were found with theslpAgene identical to that of PCR ribotype 078 strain.slpAsequence typing is valuable for comparison ofC. difficilestrains epidemic in diverse areas because the typing results are reproducible and can easily be shared. In addition,slpAsequence typing could be applied to direct typing without culture.
- Open Access
- 11 January 2007
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 12  (2) , 3110
First isolation of Clostridium difficile 027 in Japan
We report the first isolation of a variant strain of Clostridium difficile from a patient with pseudomembranous colitis in Japan. The strain was chararacterised as North American pulsed field gel electrophoresis type 1 (NAP1), PCR ribotype 027, toxinotype III.
- 11 January 2007
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 12  (2) , 3110
Open AccessFirst isolation of Clostridium difficile 027 in Japan
We report the first isolation of a variant strain of Clostridium difficile from a patient with pseudomembranous colitis in Japan. The strain was chararacterised as North American pulsed field gel electrophoresis type 1 (NAP1), PCR ribotype 027, toxinotype III.